ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

AVIR Atea Pharmaceuticals Inc

3,71
0,00 (0,00%)
Vor Marktöffnung
Zuletzt aktualisiert: 10:00:00
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Atea Pharmaceuticals Inc AVIR NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,00 0,00% 3,71 10:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
3,71
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
29.4.202413:00GLOBEAtea Announces Presentation of Data Highlighting Favorable..
27.3.202412:00GLOBEAtea Pharmaceuticals Completes Patient Enrollment in Global..
28.2.202422:18EDGAR2Form 8-K - Current report
28.2.202422:05GLOBEAtea Pharmaceuticals Reports Fourth Quarter and Full Year..
21.2.202413:00GLOBEAtea Pharmaceuticals to Host Fourth Quarter and Full Year..
03.2.202403:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.2.202403:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.2.202403:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.2.202403:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.2.202422:15EDGAR2Form 144 - Report of proposed sale of securities
01.2.202422:15EDGAR2Form 144 - Report of proposed sale of securities
01.2.202422:15EDGAR2Form 144 - Report of proposed sale of securities
08.1.202422:05GLOBEAtea Pharmaceuticals Announces Positive Initial Data from..
03.1.202413:00GLOBEAtea Pharmaceuticals to Present at the 42nd Annual J.P...
13.11.202313:00GLOBEAtea Pharmaceuticals Presents Promising Bemnifosbuvir and..
08.11.202322:43EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08.11.202322:15EDGAR2Form 8-K - Current report
08.11.202322:05GLOBEAtea Pharmaceuticals Reports Third Quarter 2023 Financial..
08.11.202313:00GLOBEAtea Pharmaceuticals Announces Participation at Upcoming..
02.11.202312:00GLOBEAtea Pharmaceuticals to Present Bemnifosbuvir and Ruzasvir..
01.11.202312:00GLOBEAtea Pharmaceuticals to Host Third Quarter 2023 Financial..
06.9.202313:00GLOBEAtea Pharmaceuticals to Present at the Morgan Stanley 21st..
08.8.202322:46EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08.8.202322:21EDGAR2Form 8-K - Current report
08.8.202322:05GLOBEAtea Pharmaceuticals Reports Second Quarter 2023 Financial..
01.8.202313:00GLOBEAtea Pharmaceuticals to Host Second Quarter 2023 Financial..
15.6.202313:00GLOBEAtea Pharmaceuticals Announces First Patient Dosed in Phase..
05.6.202322:20GLOBEAtea Pharmaceuticals to Present at the Jefferies Healthcare..
30.5.202313:00GLOBEAtea Pharmaceuticals’ Board of Directors Unanimously Rejects..
23.5.202322:05GLOBEAtea Pharmaceuticals Confirms Receipt of Unsolicited..
08.5.202322:05GLOBEAtea Pharmaceuticals Reports First Quarter 2023 Financial..
01.5.202322:05GLOBEAtea Pharmaceuticals to Host First Quarter 2023 Financial..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock